Reporting to the Executive Director, Business Development, this individual will work closely with the Business Development team to drive new business within the Northeast (NE), including lead generation, pipeline management, deal negotiation, and key account management. Additionally, they will identify and develop strategic business opportunities within pharmaceutical and biotechnology organizations across the region.
The individual will work in close collaboration with cross-functional teams to support an aggressive growth strategy focused on pharmaceutical and biotechnology companies. The Company has a significant opportunity to further penetrate existing clients, add new clients, and launch new products and services.
CellCarta is a leading provider of specialized precision medicine laboratory services to the biopharmaceutical industry. Leveraging its integrated analytical platforms in immunology, histopathology, proteomics, and genomics, as well as related specimen collection and logistics services, CellCarta supports the entire drug development cycle, from discovery to late-stage clinical trials. The Company operates globally with facilities located in Canada, USA, Belgium, Australia, and China.
Joining CellCarta means working with dedicated professionals who are focused on achieving our mission of impacting the future of patient therapy. We make a difference in the lives of patients around the world!
Join us as we make an impact on patient therapy!
As a global leader in precision medicine testing services, we partner with our clients to address the most complex biomarker and bioanalytical challenges and deliver highly customized testing solutions. With facilities located in Canada, United States, Belgium, Australia and China, CellCarta provides the expertise needed locally to support global clinical trials. CellCarta offers access to integrated analytical platforms in immunology (immune monitoring), histopathology, proteomics and genomics, as well as digital pathology/AI and sample management, logistics and kitting services. At CellCarta we are experts at assessing the immune system, whether in the context of oncology, infectious diseases, or autoimmune diseases. With a proven track record in other therapeutic areas as, such as neurological and metabolic disorders, we handle all human biological specimens and deploy relevant technologies to extract valuable information for research and diagnostic applications. We provide assay development and testing services to support a wide variety of translational research, clinical trials, and diagnostic applications. Committed to delivering the highest quality science and innovation, CellCarta recently acquired : - Biogazelle: genomics testing solutions, dPCR, qPCR & RNAseq - Reveal Biosciences: AI pathology & ImageDxTM platform - Clinical Logistics: specialty specimen logistics and kitting services - Mosaic Laboratories: multiplex immunohistochemistry assays development and deployment. Reflecting our commitment to quality, our sites hold the appropriate accreditations to support your regulatory requirements, including CAP, CLIA, ISO15189, ISO17025 and ISO13485.
View company profile →